CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-31 | Thomas Joe Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-10-31 | GMS Tenshi Holdings Pte. Ltd Chief Executive Officer | Purchase · Series A Convertible Preferred Stock | +217,372 | $100.00 | $21.7M | 250,000 |
| 2017-10-31 | GMS Tenshi Holdings Pte. Ltd Chief Executive Officer | Purchase · Warrants | +16,750,000 | 16,750,000 | ||
| 2017-10-26 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-10-26 | Brady Todd C Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-10-26 | Canute Scott A Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-10-26 | Dyrness Albert D. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-01-23 | HILZINGER KURT J Director | Option exercise | +12,036 | $0.01 | $120 | 30,554 |
| 2017-01-23 | HILZINGER KURT J Director | Option exercise · Warrant (Right to Buy) | −12,036 | 0 | ||
| 2016-12-22 | Dyrness Albert D. Director | Purchase · Warrant (Right to Buy) | +11,500 | 11,500 | ||
| 2016-12-22 | Canute Scott A Director | Purchase · Warrant (Right to Buy) | +80,500 | 80,500 | ||
| 2016-12-21 | KENYON LAWRENCE A CFO and Secretary | Grant or award | +50,000 | 93,478 | ||
| 2016-12-21 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | Grant or award | +30,000 | 66,604 | ||
| 2016-12-21 | Yamashita Elizabeth A. VP, Regulatory Affairs | Grant or award | +45,000 | 88,478 | ||
| 2016-12-21 | Gangloff Scott A. SVP, Development & Mfrg | Grant or award | +40,000 | 118,573 | ||
| 2016-12-21 | Bahrt Kenneth Chief Medical Officer | Grant or award | +50,000 | 80,985 | ||
| 2016-12-21 | Bao Kogan VP, Analytical Sciences | Grant or award | +50,000 | 71,739 | ||
| 2016-11-30 | HILZINGER KURT J Director | Other acquisition | +6,885 | 18,518 | ||
| 2016-11-28 | Smith Hoke Robin Director | Other acquisition | +1,939 | 1,939 | ||
| 2016-11-28 | Smith Hoke Robin Director | Other acquisition · Warrant (Right to Buy) | +1,260 | 1,260 |
Page 18 of 20 · 386 trades